ES2532225T3 - Cebadores de polinucleótidos para detectar mutaciones de PIK3CA - Google Patents

Cebadores de polinucleótidos para detectar mutaciones de PIK3CA Download PDF

Info

Publication number
ES2532225T3
ES2532225T3 ES12169594.4T ES12169594T ES2532225T3 ES 2532225 T3 ES2532225 T3 ES 2532225T3 ES 12169594 T ES12169594 T ES 12169594T ES 2532225 T3 ES2532225 T3 ES 2532225T3
Authority
ES
Spain
Prior art keywords
primer
mutations
primers
dna
mutation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12169594.4T
Other languages
English (en)
Spanish (es)
Inventor
Ruth Board
Jennifer Ferguson
Paul Francis Ravetto
Nicola Thelwell
David Whitcombe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qiagen Manchester Ltd
Original Assignee
Qiagen Manchester Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qiagen Manchester Ltd filed Critical Qiagen Manchester Ltd
Application granted granted Critical
Publication of ES2532225T3 publication Critical patent/ES2532225T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES12169594.4T 2007-09-28 2008-09-29 Cebadores de polinucleótidos para detectar mutaciones de PIK3CA Active ES2532225T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0719034 2007-09-28
GB0719034A GB2453173A (en) 2007-09-28 2007-09-28 Polynucleotide primers

Publications (1)

Publication Number Publication Date
ES2532225T3 true ES2532225T3 (es) 2015-03-25

Family

ID=38701889

Family Applications (6)

Application Number Title Priority Date Filing Date
ES12169604T Active ES2531055T3 (es) 2007-09-28 2008-09-29 Cebadores de polinucleótidos para detectar mutaciones de PIK3CA
ES12169594.4T Active ES2532225T3 (es) 2007-09-28 2008-09-29 Cebadores de polinucleótidos para detectar mutaciones de PIK3CA
ES12169586.0T Active ES2622885T3 (es) 2007-09-28 2008-09-29 Cebadores polinucleótidos para detectar mutaciones PIK3CA
ES12169599.3T Active ES2620289T3 (es) 2007-09-28 2008-09-29 Cebadores polinucleótidos para detectar mutaciones PIK3CA
ES10158519.8T Active ES2532141T3 (es) 2007-09-28 2008-09-29 Cebadores de polinucleótidos para detectar mutaciones de PIK3CA
ES10158523.0T Active ES2531994T3 (es) 2007-09-28 2008-09-29 Cebadores de polinucleótidos para detectar mutaciones de PIK3CA

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES12169604T Active ES2531055T3 (es) 2007-09-28 2008-09-29 Cebadores de polinucleótidos para detectar mutaciones de PIK3CA

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES12169586.0T Active ES2622885T3 (es) 2007-09-28 2008-09-29 Cebadores polinucleótidos para detectar mutaciones PIK3CA
ES12169599.3T Active ES2620289T3 (es) 2007-09-28 2008-09-29 Cebadores polinucleótidos para detectar mutaciones PIK3CA
ES10158519.8T Active ES2532141T3 (es) 2007-09-28 2008-09-29 Cebadores de polinucleótidos para detectar mutaciones de PIK3CA
ES10158523.0T Active ES2531994T3 (es) 2007-09-28 2008-09-29 Cebadores de polinucleótidos para detectar mutaciones de PIK3CA

Country Status (13)

Country Link
US (4) US8901285B2 (enExample)
EP (7) EP2505671B1 (enExample)
JP (1) JP5719593B2 (enExample)
KR (4) KR101543216B1 (enExample)
CN (4) CN103952466B (enExample)
AU (1) AU2008303400B2 (enExample)
BR (1) BRPI0817444A2 (enExample)
CA (2) CA2700710C (enExample)
ES (6) ES2531055T3 (enExample)
GB (1) GB2453173A (enExample)
MX (1) MX2010003486A (enExample)
RU (1) RU2491289C2 (enExample)
WO (1) WO2009040557A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10190171B2 (en) 2007-09-28 2019-01-29 Qiagen Manchester Limited Polynucleotide primers for detecting PIK3CA mutations

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011087928A1 (en) 2010-01-12 2011-07-21 Siemens Healthcare Diagnostics Inc. Oligonucleotides and methods for detecting kras and pik3ca mutations
JP2013081450A (ja) * 2011-09-27 2013-05-09 Arkray Inc 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用試薬キット
CN102453765B (zh) * 2011-11-03 2013-07-24 厦门艾德生物医药科技有限公司 Pik3ca基因驱动突变的检测探针、引物及试剂盒
BR112014023530A2 (pt) 2012-03-29 2017-07-18 Novartis Ag diagnóstico farmacêutico
CN102816839A (zh) * 2012-07-06 2012-12-12 杭州艾迪康医学检验中心有限公司 用于检测结直肠癌pik3ca基因热点突变位点的试剂盒
EP2711432A1 (en) * 2012-09-21 2014-03-26 Genomica S.A.U. Method for detection of BRAF and PI3K mutations
US20140272961A1 (en) * 2013-03-13 2014-09-18 Roche Molecular Systems, Inc. Methods and compositions for detecting mutations in the human pi3kca (pik3ca) gene
CN103773837A (zh) * 2013-06-25 2014-05-07 宁波有成生物医药科技有限公司 一种pik3ca基因突变荧光定量pcr检测试剂盒及检测方法
RU2549682C1 (ru) * 2013-10-21 2015-04-27 Общество с ограниченной ответственностью "БИОЧИП-ИМБ" Способ анализа соматических мутаций в гене pi3k с использованием lna-блокирующей мультиплексной пцр и последующей гибридизацией с олигонуклеотидным биологическим микрочипом (биочипом)
EP3132056B1 (en) 2014-04-18 2021-11-24 Blueprint Medicines Corporation Pik3ca fusions
CN105274188A (zh) * 2014-05-29 2016-01-27 北京雅康博生物科技有限公司 Pik3ca基因突变检测试剂盒
WO2016020710A1 (en) * 2014-08-07 2016-02-11 Pharmassist Ltd Method of determining pik3ca mutational status in a sample
US12391985B2 (en) 2014-08-07 2025-08-19 Pharmassist Ltd Method of determining PIK3CA mutational status in a sample
US10276072B2 (en) * 2014-09-03 2019-04-30 Washme Properties, Llc Illuminated sign
CN105441533B (zh) * 2014-11-29 2019-07-05 上海赛安生物医药科技有限公司 Pik3ca基因突变检测体系及其试剂盒
CN104531875A (zh) * 2014-12-30 2015-04-22 宁波有成生物医药科技有限公司 一种MyD88基因突变荧光定量PCR检测试剂盒及检测方法
KR20250078789A (ko) 2023-11-24 2025-06-04 주식회사 캐니캐티케어 반려동물의 pik3ca 유전자 돌연변이성 종양 검출용 조성물 및 이를 이용한 반려동물의 pik3ca 유전자 돌연변이성 종양 진단방법
WO2025110738A1 (ko) * 2023-11-24 2025-05-30 주식회사 캐니캐티케어 반려동물의 pik3ca 유전자 돌연변이성 종양 검출용 조성물 및 이를 이용한 반려동물의 pik3ca 유전자 돌연변이성 종양 진단방법

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61148B1 (en) 1988-03-10 1994-10-05 Ici Plc Method of detecting nucleotide sequences
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5846824A (en) 1994-02-07 1998-12-08 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
GB9208135D0 (en) 1992-04-13 1992-05-27 Ludwig Inst Cancer Res Polypeptides having kinase activity,their preparation and use
US6274327B1 (en) 1992-04-13 2001-08-14 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
US20030225013A1 (en) * 2002-05-31 2003-12-04 Isis Pharmaceuticals Inc. Antisense modulation of phosphoinositide-3-kinase, regulatory subunit 4, p150 expression
US5847972A (en) 1993-09-24 1998-12-08 Eick; Stephen Gregory Method and apparatus for graphically analzying a log-file
US6043062A (en) 1995-02-17 2000-03-28 The Regents Of The University Of California Constitutively active phosphatidylinositol 3-kinase and uses thereof
US5948664A (en) 1996-02-29 1999-09-07 The Regents Of The University Of California PI 3-kinase polypeptides
EP0877806A1 (en) * 1996-11-01 1998-11-18 Onyx Pharmaceuticals, Inc. Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
US6277563B1 (en) 1997-01-16 2001-08-21 The Regents Of The University Of California Genetic alterations associated with cancer
US5955277A (en) 1997-05-05 1999-09-21 Novo Nordisk A/S Mutant cDNA encoding the p85α subunit of phosphatidylinositol 3-kinase
US5994076A (en) * 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
US8101349B2 (en) 1997-12-23 2012-01-24 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells and their methods of use II
US6537751B1 (en) 1998-04-21 2003-03-25 Genset S.A. Biallelic markers for use in constructing a high density disequilibrium map of the human genome
AU4187499A (en) 1998-05-14 1999-11-29 Chiron Corporation Human genes and gene expression products v
GB9812768D0 (en) * 1998-06-13 1998-08-12 Zeneca Ltd Methods
US6274237B1 (en) * 1999-05-21 2001-08-14 Chisso Corporation Potentially crimpable composite fiber and a non-woven fabric using the same
AU781151B2 (en) * 1999-10-26 2005-05-12 Immusol Incorporated Ribozyme therapy for the treatment of proliferative skin and eye diseases
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
AU2001294842A1 (en) 2000-09-28 2002-04-08 Atairgin Technologies, Inc. A method of determining tumor characteristics by determining abnormal copy number or expression level of lipid-associated genes
USH2191H1 (en) * 2000-10-24 2007-06-05 Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
CN1358850A (zh) * 2000-12-13 2002-07-17 上海博德基因开发有限公司 一种新的多肽——人磷脂酰肌醇3(PtdIns 3)－激酶17.6和编码这种多肽的多核苷酸
CA2372542A1 (en) 2001-02-20 2002-08-20 Pfizer Products Inc. Transgenic animals containing a dominant negative mutant form of the p85 subunit of pi-3 kinase
US20030162174A1 (en) * 2001-06-11 2003-08-28 Sutherland John W. Detecting nucleic acid deletion sequences
WO2003025175A2 (fr) 2001-09-17 2003-03-27 Molecular Engines Laboratories Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
US20030182669A1 (en) 2002-03-19 2003-09-25 Rockman Howard A. Phosphoinositide 3-kinase mediated inhibition of GPCRs
US7955800B2 (en) 2002-06-25 2011-06-07 Advpharma Inc. Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients
US7476519B2 (en) * 2002-07-19 2009-01-13 Joseph Monforte Strategies for gene expression analysis
US7790867B2 (en) * 2002-12-05 2010-09-07 Rosetta Genomics Inc. Vaccinia virus-related nucleic acids and microRNA
RU2240350C1 (ru) * 2003-03-11 2004-11-20 НИИ онкологии им. проф. Н.Н.Петрова Минздрава РФ Способ идентификации генных мутаций и полиморфизмов
US20070054278A1 (en) 2003-11-18 2007-03-08 Applera Corporation Polymorphisms in nucleic acid molecules encoding human enzyme proteins, methods of detection and uses thereof
ES2437590T3 (es) * 2004-03-02 2014-01-13 The Johns-Hopkins University Mutaciones del gen de PIK3CA en cánceres humanos
WO2005110039A2 (en) * 2004-05-07 2005-11-24 Applera Corporation Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof
US20050287570A1 (en) * 2004-05-26 2005-12-29 Wyeth Probe arrays for expression profiling of rat genes
EA013617B1 (ru) 2005-02-24 2010-06-30 Амген Инк. Мутации рецептора эпидермального фактора роста
WO2006094149A2 (en) 2005-03-01 2006-09-08 Exact Sciences Corporation Methods and compositions for detecting adenoma
WO2006097899A1 (en) * 2005-03-14 2006-09-21 Koninklijke Philips Electronics, N.V. MEASURING AND MONITORING QoS IN SERVICE DIFFERENTIATED WIRELESS NETWORKS
GB2424886A (en) * 2005-04-04 2006-10-11 Dxs Ltd Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations
DK1948816T3 (da) * 2005-10-24 2012-04-02 Univ Johns Hopkins Forbedrede fremgangsmåder til beaming
JP4477575B2 (ja) * 2005-12-14 2010-06-09 株式会社日立製作所 大腸がんの検査に使用する遺伝子セット
US20110177960A1 (en) * 2006-03-10 2011-07-21 Ellen Murphy Microarray for monitoring gene expression in multiple strains of Streptococcus pneumoniae
GB2453173A (en) 2007-09-28 2009-04-01 Dxs Ltd Polynucleotide primers
WO2009071082A2 (en) 2007-12-03 2009-06-11 Santaris Pharma A/S Rna antagonist compounds for the modulation of pik3ca expression

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10190171B2 (en) 2007-09-28 2019-01-29 Qiagen Manchester Limited Polynucleotide primers for detecting PIK3CA mutations
US10196692B2 (en) 2007-09-28 2019-02-05 Qiagen Manchester Limited Polynucleotide primers for detecting PIK3CA mutations

Also Published As

Publication number Publication date
CA2700710A1 (en) 2009-04-02
US20160032408A1 (en) 2016-02-04
EP2505671A1 (en) 2012-10-03
US9863003B2 (en) 2018-01-09
EP2236627A1 (en) 2010-10-06
EP2205760A2 (en) 2010-07-14
GB2453173A (en) 2009-04-01
WO2009040557A2 (en) 2009-04-02
KR20150038661A (ko) 2015-04-08
CN103695558A (zh) 2014-04-02
CA2700710C (en) 2018-08-21
US20110027779A1 (en) 2011-02-03
EP2239341A8 (en) 2010-12-01
EP2239341B1 (en) 2015-01-14
JP5719593B2 (ja) 2015-05-20
EP2505673B1 (en) 2017-02-01
US10190171B2 (en) 2019-01-29
EP2505673A1 (en) 2012-10-03
EP2236627A8 (en) 2010-12-01
AU2008303400B2 (en) 2013-09-26
ES2620289T3 (es) 2017-06-28
ES2622885T3 (es) 2017-07-07
JP2010539920A (ja) 2010-12-24
RU2010116772A (ru) 2011-11-10
EP2505671B1 (en) 2017-02-01
ES2531994T3 (es) 2015-03-23
EP2508624B1 (en) 2015-01-14
ES2532141T3 (es) 2015-03-24
CN102119222A (zh) 2011-07-06
CN103952466A (zh) 2014-07-30
EP2508624A1 (en) 2012-10-10
EP2205760B1 (en) 2012-06-27
KR101543215B1 (ko) 2015-08-07
CN102119222B (zh) 2015-11-25
EP2505672A1 (en) 2012-10-03
KR20150038659A (ko) 2015-04-08
CN103952466B (zh) 2016-07-06
CN103834724A (zh) 2014-06-04
US20160040255A1 (en) 2016-02-11
US8901285B2 (en) 2014-12-02
GB0719034D0 (en) 2007-11-07
KR101543214B1 (ko) 2015-08-07
CN103834724B (zh) 2016-05-25
KR101543216B1 (ko) 2015-08-07
KR20100101070A (ko) 2010-09-16
US10196692B2 (en) 2019-02-05
ES2531055T3 (es) 2015-03-10
EP2505672B1 (en) 2015-01-14
MX2010003486A (es) 2010-08-09
EP2236627B1 (en) 2015-01-14
KR20150038660A (ko) 2015-04-08
CN103695558B (zh) 2016-01-20
CA3010064A1 (en) 2009-04-02
RU2491289C2 (ru) 2013-08-27
US20140141425A1 (en) 2014-05-22
BRPI0817444A2 (pt) 2015-06-16
KR101548758B1 (ko) 2015-09-01
AU2008303400A1 (en) 2009-04-02
WO2009040557A3 (en) 2009-05-14
EP2239341A1 (en) 2010-10-13

Similar Documents

Publication Publication Date Title
ES2532225T3 (es) Cebadores de polinucleótidos para detectar mutaciones de PIK3CA
EP3286334A1 (en) Method to increase sensitivity of next generation sequencing
AU2012296717A1 (en) Prognostic methodology
Suda et al. Use of real-time RT-PCR for the detection of allelic expression of an imprinted gene
EP2313529A2 (en) Method for determining reduced predisposition to cancer based on genetic profile
Rogar Single Nucleotide Polymorphisms of the Chromosome Segregation Genes Involved in the Development of Gastric Cancer